Joseph France

Stock Analyst at Cantor Fitzgerald

(2.64)
# 2,031
Out of 5,143 analysts
56
Total ratings
66.67%
Success rate
10.72%
Average return

Stocks Rated by Joseph France

Acadia Healthcare Company
Sep 14, 2023
Maintains: Neutral
Price Target: $83$85
Current: $15.19
Upside: +459.76%
HCA Healthcare
Apr 24, 2023
Maintains: Buy
Price Target: $285$320
Current: $466.19
Upside: -31.36%
Elevance Health
Apr 21, 2023
Maintains: Buy
Price Target: $565$550
Current: $372.01
Upside: +47.85%
UnitedHealth Group
Apr 17, 2023
Maintains: Buy
Price Target: $590$600
Current: $354.54
Upside: +69.23%
Cross Country Healthcare
Mar 10, 2023
Initiates: Buy
Price Target: $30
Current: $8.93
Upside: +235.95%
CVS Health
Jun 17, 2022
Initiates: Buy
Price Target: $120
Current: $82.64
Upside: +45.21%
Tenet Healthcare
Jun 17, 2022
Initiates: Buy
Price Target: $80
Current: $189.21
Upside: -57.72%
Universal Health Services
Jun 17, 2022
Initiates: Hold
Price Target: $115
Current: $205.73
Upside: -44.10%
The Cigna Group
Jun 17, 2022
Initiates: Hold
Price Target: $270
Current: $279.86
Upside: -3.52%
Molina Healthcare
Jun 17, 2022
Initiates: Hold
Price Target: $310
Current: $198.61
Upside: +56.08%
Initiates: Hold
Price Target: $5
Current: $3.36
Upside: +48.81%
Initiates: Buy
Price Target: $510
Current: $266.20
Upside: +91.59%
Initiates: Buy
Price Target: $100
Current: $45.35
Upside: +120.53%
Maintains: Overweight
Price Target: $42$50
Current: $174.94
Upside: -71.42%
Maintains: Neutral
Price Target: $103$107
Current: $87.41
Upside: +22.41%
Downgrades: Neutral
Price Target: $12$10
Current: $2.12
Upside: +371.70%
Initiates: Overweight
Price Target: $77
Current: $111.02
Upside: -30.64%
Maintains: Overweight
Price Target: $45$46
Current: $36.69
Upside: +25.37%
Maintains: Neutral
Price Target: $75$80
Current: $79.01
Upside: +1.25%
Initiates: Overweight
Price Target: $34
Current: $43.27
Upside: -21.42%
Maintains: Overweight
Price Target: $20$21
Current: $17.83
Upside: +17.81%
Initiates: Overweight
Price Target: $60
Current: $35.57
Upside: +68.71%
Initiates: Overweight
Price Target: $7
Current: $25.22
Upside: -72.24%